Referred to the House Committee on Energy and Commerce.
To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.
Chamber: United States House of Representatives (The United States of America)
Sponsors
(2)
MDMaxine Dexter
Democrat · Primary
MLMichael Lawler
Republican · Primary
Legislative Votes
No votes have been held on this legislation yet.